405 related articles for article (PubMed ID: 28882625)
21. Xenobiotic-induced liver injury and fibrosis.
Österreicher CH; Trauner M
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
[TBL] [Abstract][Full Text] [Related]
22. Lamotrigine-induced vanishing bile duct syndrome in a child.
Bhayana H; Appasani S; Thapa BR; Das A; Singh K
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
[No Abstract] [Full Text] [Related]
23. How the biliary tree maintains immune tolerance?
Zhang H; Leung PSC; Gershwin ME; Ma X
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1367-1373. PubMed ID: 28844953
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
[TBL] [Abstract][Full Text] [Related]
25. Genetic determinants of cholangiopathies: Molecular and systems genetics.
Reichert MC; Hall RA; Krawczyk M; Lammert F
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1484-1490. PubMed ID: 28757171
[TBL] [Abstract][Full Text] [Related]
26. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.
Forbes GM; Jeffrey GP; Shilkin KB; Reed WD
Gastroenterology; 1992 Apr; 102(4 Pt 1):1385-8. PubMed ID: 1551543
[TBL] [Abstract][Full Text] [Related]
27. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
28. [Secondary drug-induced cholestasis with bile duct involvement].
Horsmans Y; Harvengt C
Acta Gastroenterol Belg; 1991; 54(1):27-33. PubMed ID: 2058347
[TBL] [Abstract][Full Text] [Related]
29. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.
Alvarez-Sola G; Uriarte I; Latasa MU; Jimenez M; Barcena-Varela M; Santamaría E; Urtasun R; Rodriguez-Ortigosa C; Prieto J; Berraondo P; Fernandez-Barrena MG; Berasain C; Avila MA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1326-1334. PubMed ID: 28709961
[TBL] [Abstract][Full Text] [Related]
30. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
Zen Y; Grammatikopoulos T; Heneghan MA; Vergani D; Mieli-Vergani G; Portmann BC
Am J Surg Pathol; 2012 Oct; 36(10):1555-61. PubMed ID: 22982898
[TBL] [Abstract][Full Text] [Related]
31. Tetracycline-induced bile duct paucity and prolonged cholestasis.
Hunt CM; Washington K
Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
[TBL] [Abstract][Full Text] [Related]
32. Advances in the generation of bioengineered bile ducts.
Justin AW; Saeb-Parsy K; Markaki AE; Vallier L; Sampaziotis F
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1532-1538. PubMed ID: 29097260
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced cholestasis.
Erlinger S
J Hepatol; 1997; 26 Suppl 1():1-4. PubMed ID: 9138122
[TBL] [Abstract][Full Text] [Related]
34. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
35. Repopulating the biliary tree from the peribiliary glands.
de Jong IEM; van Leeuwen OB; Lisman T; Gouw ASH; Porte RJ
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1524-1531. PubMed ID: 28778591
[TBL] [Abstract][Full Text] [Related]
36. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
37. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
38. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
39. The ascending pathophysiology of cholestatic liver disease.
Jansen PL; Ghallab A; Vartak N; Reif R; Schaap FG; Hampe J; Hengstler JG
Hepatology; 2017 Feb; 65(2):722-738. PubMed ID: 27981592
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
